DISCOVERY: prevalence of transthyretin (TTR) mutations in a US-centric patient population suspected of having cardiac amyloidosis

Effects of Patisiran, an RNA Interference Therapeutic, on Cardiac Parameters in Patients With Hereditary Transthyretin-Mediated Amyloidosis

(2019) Scott D. Solomon et al.   CIRCULATION

Transthyretin cardiac amyloidosis in continental Western Europe: an insight through the Transthyretin Amyloidosis Outcomes Survey (THAOS)

(2019) Thibaud Damy et al.   EUROPEAN HEART JOURNAL

Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry

(2019) Scott M. Damrauer et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cardiac amyloidosis: An update on pathophysiology, diagnosis, and treatment

(2018) Omar K. Siddiqi et al.   TRENDS IN CARDIOVASCULAR MEDICINE

A new staging system for cardiac transthyretin amyloidosis

(2017) Julian D Gillmore et al.   EUROPEAN HEART JOURNAL

Transthyretin Cardiac Amyloidosis

(2017) Anit K. Mankad et al.   Current Cardiology Reports

Identification of Transthyretin Cardiac Amyloidosis Using Serum Retinol-Binding Protein 4 and a Clinical Prediction Model

(2017) Marios Arvanitis et al.   JAMA Cardiology

Early intervention with tafamidis provides long-term (5.5-year) delay of neurologic progression in transthyretin hereditary amyloid polyneuropathy

(2016) Márcia Waddington Cruz et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Wild-Type Transthyretin Cardiac Amyloidosis: Novel Insights From Advanced Imaging

(2016) David L. Narotsky et al.   CANADIAN JOURNAL OF CARDIOLOGY

Nonbiopsy Diagnosis of Cardiac Transthyretin AmyloidosisCLINICAL PERSPECTIVE

(2016) Julian D. Gillmore et al.   CIRCULATION

Afro-Caribbean Heart Failure in the United KingdomCLINICAL PERSPECTIVE

(2016) Jason N. Dungu et al.   Circulation-Heart Failure

Genotype and Phenotype of Transthyretin Cardiac Amyloidosis

(2016) Mathew S. Maurer et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

“Red-flag” symptom clusters in transthyretin familial amyloid polyneuropathy

(2016) Isabel Conceição et al.   JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM

Familial amyloid polyneuropathy: When does it stop to be asymptomatic and need a treatment?

(2016) D. Adams et al.   REVUE NEUROLOGIQUE

The prevalence and distribution of the amyloidogenic transthyretin (TTR) V122I allele in Africa

(2016) Daniel R. Jacobson et al.   Molecular Genetics & Genomic Medicine

Prevalence of the amyloidogenic transthyretin (TTR) V122I allele in 14 333 African–Americans

(2015) Daniel R. Jacobson et al.   AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS

Evolving landscape in the management of transthyretin amyloidosis

(2015) Philip N. Hawkins et al.   ANNALS OF MEDICINE

Tafamidis in Transthyretin Amyloid Cardiomyopathy: Effects on Transthyretin Stabilization and Clinical Outcomes

(2015) M. S. Maurer et al.   Circulation-Heart Failure

Wild-type transthyretin amyloidosis as a cause of heart failure with preserved ejection fraction

(2015) Esther González-López et al.   EUROPEAN HEART JOURNAL

Prevalence and clinical phenotype of hereditary transthyretin amyloid cardiomyopathy in patients with increased left ventricular wall thickness

(2015) Thibaud Damy et al.   EUROPEAN HEART JOURNAL

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology

(2015) Sue Richards et al.   GENETICS IN MEDICINE

Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments

(2015) Yoshiki Sekijima   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Cardiac Findings and Events Observed in an Open-Label Clinical Trial of Tafamidis in Patients with non-Val30Met and non-Val122Ile Hereditary Transthyretin Amyloidosis

(2015) Thibaud Damy et al.   Journal of Cardiovascular Translational Research

Natural history and therapy of TTR-cardiac amyloidosis: emerging disease-modifying therapies from organ transplantation to stabilizer and silencer drugs

(2014) Adam Castaño et al.   HEART FAILURE REVIEWS

Online Registry for Mutations in Hereditary Amyloidosis Including Nomenclature Recommendations

(2014) Dorota M. Rowczenio et al.   HUMAN MUTATION

Cardiac amyloidosis: Updates in diagnosis and management

(2013) Dania Mohty et al.   Archives of Cardiovascular Diseases

Effect on disability and safety of Tafamidis in late onset of Met30 transthyretin familial amyloid polyneuropathy

(2013) P. Lozeron et al.   EUROPEAN JOURNAL OF NEUROLOGY

Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy

(2013) Teresa Coelho et al.   JOURNAL OF NEUROLOGY

Senile Systemic Amyloidosis: Clinical Features at Presentation and Outcome

(2013) Jennifer H. Pinney et al.   Journal of the American Heart Association

Transthyretin (TTR) Cardiac Amyloidosis

(2012) Frederick L. Ruberg et al.   CIRCULATION

THAOS – The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis

(2012) Teresa Coelho et al.   CURRENT MEDICAL RESEARCH AND OPINION

Cardiac transthyretin amyloidosis

(2012) Jason N Dungu et al.   HEART

Transthyretin Cardiac Amyloidoses in Older North Americans

(2012) Kumar Dharmarajan et al.   JOURNAL OF THE AMERICAN GERIATRICS SOCIETY

Amyloid Neuropathies

(2012) Susan C. Shin et al.   MOUNT SINAI JOURNAL OF MEDICINE

Cardiac phenotype and clinical outcome of familial amyloid polyneuropathy associated with transthyretin alanine 60 variant

(2011) P. T. Sattianayagam et al.   EUROPEAN HEART JOURNAL

Cardiac amyloidosis in African Americans: Comparison of clinical and laboratory features of transthyretin V122I amyloidosis and immunoglobulin light chain amyloidosis

(2009) Lawreen H. Connors et al.   AMERICAN HEART JOURNAL